Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: ValuEngine, Inc.
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Agios Pharmaceuticals Inc Prices Initial Public Offering

Tuesday, 23 Jul 2013 11:03pm EDT 

Agios Pharmaceuticals Inc announced the pricing of initial public offering of 5,888,888 shares of common stock at a public offering price of $18.00 per share, before underwriting discounts. All of the shares in the offering are being sold by Agios. In addition, Agios has granted the underwriters a 30-day option to purchase up to 883,333 additional shares of common stock from Agios at the public offering price, less the underwriting discount. Agios' common stock has been approved for listing on the NASDAQ Global Select Market and is expected to begin trading under the ticker symbol AGIO on July 24, 2013. The offering is expected to close on July 29, 2013. J.P. Morgan and Goldman, Sachs & Co. are acting as joint book-running managers for the offering. Cowen and Company and Leerink Swan are acting as co-managers. 

Company Quote

-4.81 -3.98%
30 Jan 2015